Cargando…
Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial
OBJECTIVE: Dyslipidemia has been considered as a major risk factor for coronary heart disease. Alternative medicine has a significant role in treatment of dyslipidemia. There are controversial findings regarding the effects of sour tea on dyslipidemia. The aim of this study was to evaluate the impac...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787994/ https://www.ncbi.nlm.nih.gov/pubmed/29387571 |
_version_ | 1783296038128320512 |
---|---|
author | Hajifaraji, Majid Matlabi, Mohammad Ahmadzadeh-Sani, Farihe Mehrabi, Yadollah Rezaee, Mohammad Salem Hajimehdipour, Homa Hasanzadeh, Abbas Roghani, Katayoun |
author_facet | Hajifaraji, Majid Matlabi, Mohammad Ahmadzadeh-Sani, Farihe Mehrabi, Yadollah Rezaee, Mohammad Salem Hajimehdipour, Homa Hasanzadeh, Abbas Roghani, Katayoun |
author_sort | Hajifaraji, Majid |
collection | PubMed |
description | OBJECTIVE: Dyslipidemia has been considered as a major risk factor for coronary heart disease. Alternative medicine has a significant role in treatment of dyslipidemia. There are controversial findings regarding the effects of sour tea on dyslipidemia. The aim of this study was to evaluate the impact of aqueous extract of dried calyx of sour tea on polygenic dyslipidemia. MATERIALS AND METHODS: This clinical trial was done on 43 adults (30-60 years old) with polygenic dyslipidemia that were randomly assigned to the intervention and control groups. The control group was trained in lifestyle modifications at baseline. The intervention group was trained for lifestyle modifications at baseline and received two cups of sour tea daily, and both groups were followed up for 12 weeks. Lipid profile was evaluated at baseline, and six and 12 weeks following the intervention. In addition, dietary and physical activity assessed at baseline for twelve weeks. RESULTS: Mean concentration of total cholesterol, HDL-C and LDL-C significantly decreased by up to 9.46%, 8.33%, and 9.80%, respectively, after 12 weeks in the intervention group in comparison to their baseline values. However, LDL-C/HDL-C ratio significantly increased by up to 3.15%, following 12 weeks in the control group in comparison to their baseline values. This study showed no difference in lipid profiles between the two groups, except for HDL-C concentrations. CONCLUSION: sour tea may have significant positive effects on lipid profile of polygenic dyslipidemia subjects and these effect might be attributed to its anthocyanins and inflation factor content. Therefore, sour tea intake with recommended dietary patterns and physical activity can be useful in regulation of lipid profile in patients with polygenic dyslipidemia. |
format | Online Article Text |
id | pubmed-5787994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Mashhad University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-57879942018-01-31 Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial Hajifaraji, Majid Matlabi, Mohammad Ahmadzadeh-Sani, Farihe Mehrabi, Yadollah Rezaee, Mohammad Salem Hajimehdipour, Homa Hasanzadeh, Abbas Roghani, Katayoun Avicenna J Phytomed Original Article OBJECTIVE: Dyslipidemia has been considered as a major risk factor for coronary heart disease. Alternative medicine has a significant role in treatment of dyslipidemia. There are controversial findings regarding the effects of sour tea on dyslipidemia. The aim of this study was to evaluate the impact of aqueous extract of dried calyx of sour tea on polygenic dyslipidemia. MATERIALS AND METHODS: This clinical trial was done on 43 adults (30-60 years old) with polygenic dyslipidemia that were randomly assigned to the intervention and control groups. The control group was trained in lifestyle modifications at baseline. The intervention group was trained for lifestyle modifications at baseline and received two cups of sour tea daily, and both groups were followed up for 12 weeks. Lipid profile was evaluated at baseline, and six and 12 weeks following the intervention. In addition, dietary and physical activity assessed at baseline for twelve weeks. RESULTS: Mean concentration of total cholesterol, HDL-C and LDL-C significantly decreased by up to 9.46%, 8.33%, and 9.80%, respectively, after 12 weeks in the intervention group in comparison to their baseline values. However, LDL-C/HDL-C ratio significantly increased by up to 3.15%, following 12 weeks in the control group in comparison to their baseline values. This study showed no difference in lipid profiles between the two groups, except for HDL-C concentrations. CONCLUSION: sour tea may have significant positive effects on lipid profile of polygenic dyslipidemia subjects and these effect might be attributed to its anthocyanins and inflation factor content. Therefore, sour tea intake with recommended dietary patterns and physical activity can be useful in regulation of lipid profile in patients with polygenic dyslipidemia. Mashhad University of Medical Sciences 2018 /pmc/articles/PMC5787994/ /pubmed/29387571 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Hajifaraji, Majid Matlabi, Mohammad Ahmadzadeh-Sani, Farihe Mehrabi, Yadollah Rezaee, Mohammad Salem Hajimehdipour, Homa Hasanzadeh, Abbas Roghani, Katayoun Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial |
title | Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial |
title_full | Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial |
title_fullStr | Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial |
title_full_unstemmed | Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial |
title_short | Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial |
title_sort | effects of aqueous extracts of dried calyx of sour tea (hibiscus sabdariffa l.) on polygenic dyslipidemia: a randomized clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787994/ https://www.ncbi.nlm.nih.gov/pubmed/29387571 |
work_keys_str_mv | AT hajifarajimajid effectsofaqueousextractsofdriedcalyxofsourteahibiscussabdariffalonpolygenicdyslipidemiaarandomizedclinicaltrial AT matlabimohammad effectsofaqueousextractsofdriedcalyxofsourteahibiscussabdariffalonpolygenicdyslipidemiaarandomizedclinicaltrial AT ahmadzadehsanifarihe effectsofaqueousextractsofdriedcalyxofsourteahibiscussabdariffalonpolygenicdyslipidemiaarandomizedclinicaltrial AT mehrabiyadollah effectsofaqueousextractsofdriedcalyxofsourteahibiscussabdariffalonpolygenicdyslipidemiaarandomizedclinicaltrial AT rezaeemohammadsalem effectsofaqueousextractsofdriedcalyxofsourteahibiscussabdariffalonpolygenicdyslipidemiaarandomizedclinicaltrial AT hajimehdipourhoma effectsofaqueousextractsofdriedcalyxofsourteahibiscussabdariffalonpolygenicdyslipidemiaarandomizedclinicaltrial AT hasanzadehabbas effectsofaqueousextractsofdriedcalyxofsourteahibiscussabdariffalonpolygenicdyslipidemiaarandomizedclinicaltrial AT roghanikatayoun effectsofaqueousextractsofdriedcalyxofsourteahibiscussabdariffalonpolygenicdyslipidemiaarandomizedclinicaltrial |